Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001641172-25-001625
Filing Date
2025-03-31
Accepted
2025-03-31 15:05:20
Documents
53
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1003127
2 ex31-1.htm EX-31.1 17533
3 ex31-2.htm EX-31.2 17556
4 ex32-1.htm EX-32.1 8704
  Complete submission text file 0001641172-25-001625.txt   4279398

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE cqens-20241231.xsd EX-101.SCH 29897
6 XBRL CALCULATION FILE cqens-20241231_cal.xml EX-101.CAL 40912
7 XBRL DEFINITION FILE cqens-20241231_def.xml EX-101.DEF 133970
8 XBRL LABEL FILE cqens-20241231_lab.xml EX-101.LAB 297257
9 XBRL PRESENTATION FILE cqens-20241231_pre.xml EX-101.PRE 231572
55 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 432826
Mailing Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419
Business Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419 612-812-2037
CQENS Technologies Inc. (Filer) CIK: 0001479915 (see all company filings)

EIN.: 271521364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-55470 | Film No.: 25792227
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)